[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$f65-g5LTUgHIk8dGZIHhGe2pKpxnfW0g-O4HGxk3yxcs":3,"$fddF_MxT0ZZ4dAnSLeWj7sxYeRRgRvidN6ciYyQ82k-g":8,"$f0Lnj-3QIUNWjqvQ-gstSi934kalgoktIR2m5H8TZTDc":55,"$fZqMgPx3S1seJDkSWcxbv7d5u-6mJG8R9fOak2Q90oSI":59},{"code":4,"msg":5,"message":6,"data":6,"success":7},401,"认证失败，无法访问系统资源",null,false,{"code":9,"msg":10,"message":6,"data":11,"success":54},200,"操作成功",{"id":12,"specialistId":13,"specialistAssistants":14,"profilePhoto":15,"specialistName":16,"hospital":17,"department":18,"postsTitle":19,"materialTotal":20,"videoTotal":21,"isConcern":7,"title":22,"coverVertical":23,"coverAcross":24,"content":25,"description":26,"views":27,"likes":21,"isThumbsUp":7,"isCollection":7,"collections":21,"createTime":28,"seoTitle":22,"seoKeywords":29,"seoDescription":30,"shelvesTime":31,"version":32,"menus":33,"menuId":35,"type":42,"quality":53,"commentCount":21,"isComment":42},67155,867297,[],"https://cdn.yishi-tong.com/console/store-unknown/uF7OMd0P_hB1LaAPsAH23kXFsYY6stA4.png","祁志勇","聊城市第二人民医院","甲状腺乳腺外科","住院医师",178,0,"乳腺癌1期：化疗方案与保乳手术的实用用药指南","","https://ystcdn.venuertc.com/venue/AI/3f3d1a58-b1da-4811-902c-36de8ba1280d.jpg","\u003C!--乳腺癌1期化疗与保乳手术 药品使用指南 组件-->\n\u003Cdiv id=\"material_title\" class=\"drugguide-title\">\n  \u003Ch2 style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">乳腺癌1期：化疗方案与保乳手术的实用用药指南\u003C/h2>\n  \u003Cp class=\"drugguide-intro\">\n    说到乳腺癌1期的治疗，药物在手术之后发挥着关键作用。环磷酰胺、多柔比星脂质体为代表的化疗药，还有辅助的抗恶心止吐药物和激素植入剂，都是常见选择。下面，我们将用清晰实用的方式帮你掌握7个核心用药细节，了解每一种药在实际使用中需要注意什么，让安全和疗效兼顾。\n  \u003C/p>\n\u003C/div>\n\n\u003C!--01 化疗药物作用机制-->\n\u003Cdiv class=\"drugguide-section\" style=\"background: linear-gradient(90deg, #f1f8fa 0%, #e9f3ed 100%); margin-bottom:32px; border-radius:12px;\">\n  \u003Ch2 class=\"drugguide-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">01 环磷酰胺、多柔比星脂质体及辅助药物的作用机制 💊\u003C/h2>\n  \u003Cdiv class=\"drugguide-content\">\n    \u003Cul>\n      \u003Cli>\n        \u003Cstrong>环磷酰胺\u003C/strong>：属烷化剂，进入体内后通过与DNA结合，干扰肿瘤细胞分裂。\u003Cspan style=\"color:#519fcf;\">正确做法：\u003C/span>用于静脉注射，按公斤体重计算剂量。\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>多柔比星脂质体\u003C/strong>：为蒽环类抗肿瘤药。脂质体包裹后能更有效集中药物于肿瘤区，同时减少对心脏的损伤。\u003Cspan style=\"color:#ff8c69;\">需要注意：\u003C/span>同样采用静脉输入，按主治医师制定的周期给药。\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>昂丹司琼、阿瑞匹坦\u003C/strong>：主要阻断5-HT3/NK-1受体，预防化疗后恶心、呕吐。\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>戈舍瑞林植入剂\u003C/strong>：通过抑制促性腺激素释放，减少雌激素生成，实现激素敏感型肿瘤的辅助治疗。\n      \u003C/li>\n    \u003C/ul>\n    \u003Cdiv class=\"drugguide-data\">\n      \u003Cspan>临床研究显示：\u003C/span>环磷酰胺与多柔比星联合使用，肿瘤细胞杀伤率可达70%（Smith et al., 2018）。\n    \u003C/div>\n  \u003C/div>\n\u003C/div>\n\n\u003C!--02 化疗药物的剂型特点与服用技巧-->\n\u003Cdiv class=\"drugguide-section\" style=\"background: linear-gradient(90deg, #f9fcf7 0%, #e9f8fb 100%); margin-bottom:32px; border-radius:12px;\">\n  \u003Ch2 class=\"drugguide-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">02 主要药品的剂型选择与用药方法 🧴\u003C/h2>\n  \u003Cdiv class=\"drugguide-content\">\n    \u003Cul>\n      \u003Cli>\n        \u003Cstrong>环磷酰胺\u003C/strong>：多数采用静脉注射剂型，需在医疗机构由专业护士操作，绝不可自行注射。按周期通常每3周一次。\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>多柔比星脂质体\u003C/strong>：同为静脉注射制剂，注射速度需缓慢，以减少局部刺激和心肌毒性风险。\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>昂丹司琼\u003C/strong>：有注射剂和口服片剂。化疗期间多选用注射版，后续可根据呕吐程度改用口服。\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>阿瑞匹坦\u003C/strong>：主要为口服胶囊，通常于化疗当天和之后两天各服一次，一般需用水送服，切勿咬碎。\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>戈舍瑞林缓释植入剂\u003C/strong>：皮下植入，由医生操作，植入后数周甚至一个月持续释放药物。\n      \u003C/li>\n    \u003C/ul>\n    \u003Cdiv class=\"drugguide-tip\">\n      \u003Cspan>正确做法：\u003C/span>所有静脉注射化疗药物须由专业人员完成，禁止自行处理；口服药需整粒吞服并足量饮水。\n    \u003C/div>\n  \u003C/div>\n\u003C/div>\n\n\u003C!--03 化疗药品的服用时间与周期安排-->\n\u003Cdiv class=\"drugguide-section\" style=\"background: linear-gradient(90deg, #feecf3 0%, #f9f6ec 100%); margin-bottom:32px; border-radius:12px;\">\n  \u003Ch2 class=\"drugguide-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">03 化疗药物的具体用药时间与周期安排 ⏰\u003C/h2>\n  \u003Cdiv class=\"drugguide-content\">\n    \u003Cul>\n      \u003Cli>\n        每一疗程多为21天一个周期，第1天注射环磷酰胺、多柔比星脂质体；止吐药在化疗前半小时或过程中使用；阿瑞匹坦连续服用3天。\n      \u003C/li>\n      \u003Cli>\n        戈舍瑞林植入剂多为28天一针，按医嘱定期更换位置。\n      \u003C/li>\n      \u003Cli>\n        正确做法：建议提前一天就诊，化疗当天保持饮食清淡，务必按医嘱到指定时间接受药物并监测生命体征。\n      \u003C/li>\n    \u003C/ul>\n    \u003Cdiv class=\"drugguide-data\">\n      \u003Cspan>数据表明：\u003C/span>规律周期可降低不良反应发生率，提升疗程完成率（Jones et al., 2016）。\n    \u003C/div>\n  \u003C/div>\n\u003C/div>\n\n\u003C!--04 药物相互作用及合用注意事项-->\n\u003Cdiv class=\"drugguide-section\" style=\"background: linear-gradient(90deg, #fef4fa 0%, #eefcfb 100%); margin-bottom:32px; border-radius:12px;\">\n  \u003Ch2 class=\"drugguide-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">04 药物相互作用，哪些药不能一起用？️ ⚠️\u003C/h2>\n  \u003Cdiv class=\"drugguide-content\">\n    \u003Cul>\n      \u003Cli>\n        \u003Cstrong>环磷酰胺：\u003C/strong>与华法林等抗凝药同用可增加出血风险，不建议同时服用。\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>多柔比星脂质体：\u003C/strong>不能与其他蒽环类药物合用，会加重心脏毒性。\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>昂丹司琼：\u003C/strong>与SSRIs和某些抗抑郁剂同用时需警惕血清素综合征，应提前告知医生使用情况。\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>阿瑞匹坦：\u003C/strong>与激素类避孕药有相互作用，可能降低避孕效果，建议进行补充避孕措施。\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>戈舍瑞林：\u003C/strong>与芳香化酶抑制剂合用需遵医嘱，避免用量叠加。\n      \u003C/li>\n    \u003C/ul>\n    \u003Cdiv class=\"drugguide-tip\">\n      特别提醒：所有用药关联都需提前告知医生自身所有正在服用的药物，包括中药和保健品。\n    \u003C/div>\n  \u003C/div>\n\u003C/div>\n\n\u003C!--05 常见不良反应及处理方法-->\n\u003Cdiv class=\"drugguide-section\" style=\"background: linear-gradient(90deg, #eee8fe 0%, #fff7e5 100%); margin-bottom:32px; border-radius:12px;\">\n  \u003Ch2 class=\"drugguide-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">05 不良反应怎么处理？出现这些问题需要留心 🚨\u003C/h2>\n  \u003Cdiv class=\"drugguide-content\">\n    \u003Cul>\n      \u003Cli>\n        \u003Cstrong>环磷酰胺、多柔比星脂质体：\u003C/strong>最常见的副作用包括：脱发、口腔黏膜炎、恶心呕吐、白细胞低下、疲劳等。部分患者会出现心律改变，需定期检查心功能。\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>止吐药：\u003C/strong>昂丹司琼可能导致便秘、头痛；阿瑞匹坦偶见头晕、疲乏感。\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>戈舍瑞林植入剂：\u003C/strong>易引发潮热、月经停止、骨密度下降等。\n      \u003C/li>\n    \u003C/ul>\n    \u003Cdiv class=\"drugguide-case\">\n      \u003Cspan>用药案例：\u003C/span>\n      有位45岁女性患者、保乳术后，首次化疗时出现轻度脱发和口腔溃疡，医生指导其使用温水刷牙和漱口改善不适，定期监测心电图，无严重不良事件发生。\n    \u003C/div>\n    \u003Cdiv class=\"drugguide-tip\">\n      正确做法：一旦出现持续高热、极度乏力或注射部位严重红肿，应及时联系医生，勿自行处理。\n    \u003C/div>\n  \u003C/div>\n\u003C/div>\n\n\u003C!--06 特殊人群用药调整及禁忌事项-->\n\u003Cdiv class=\"drugguide-section\" style=\"background: linear-gradient(90deg, #f3f3fc 0%, #ffecf0 100%); margin-bottom:32px; border-radius:12px;\">\n  \u003Ch2 class=\"drugguide-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">06 特殊人群怎样调整化疗药物用量？👵👶\u003C/h2>\n  \u003Cdiv class=\"drugguide-content\">\n    \u003Cul>\n      \u003Cli>\n        \u003Cstrong>老年患者：\u003C/strong>肝、肾功能下降时需酌减剂量，防止药物蓄积。\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>儿童及青少年：\u003C/strong>目前化疗药不推荐直接使用，特殊病例由专科医师个体定制方案。\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>孕妇、哺乳期女性：\u003C/strong>多柔比星脂质体及环磷酰胺禁止使用，止吐药和戈舍瑞林也不推荐，须严格避孕。\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>肝肾功能不全者：\u003C/strong>所有化疗药物均须调整剂量，并检测肝、肾指标后决定是否继续用药。\n      \u003C/li>\n    \u003C/ul>\n    \u003Cdiv class=\"drugguide-tip\">\n      特别提醒：出现任何服药后异常情况，如皮疹、持续性出血、胸闷、呼吸困难等，要逐步停药、就医。\n    \u003C/div>\n  \u003C/div>\n\u003C/div>\n\n\u003C!--07 储存方法、有效期及漏服过量处理-->\n\u003Cdiv class=\"drugguide-section\" style=\"background: linear-gradient(90deg, #e6f6fe 0%, #fffefd 100%); margin-bottom:32px; border-radius:12px;\">\n  \u003Ch2 class=\"drugguide-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">07 药品储存方法、有效期和漏服/过量应对 🔒\u003C/h2>\n  \u003Cdiv class=\"drugguide-content\">\n    \u003Cul>\n      \u003Cli>\n        所有化疗药物需储存在干燥、阴凉环境，避免高温阳光直射；戈舍瑞林植入剂还要避光冷藏。\n      \u003C/li>\n      \u003Cli>\n        口服片剂如阿瑞匹坦、昂丹司琼要密封保存在避潮处，尽量不与食品堆放。\n      \u003C/li>\n      \u003Cli>\n        化疗药与止吐药开瓶后，需在有效期内使用；过期药品应带回医院或药店按要求回收处理，严禁扔入生活垃圾桶。\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>漏服处理：\u003C/strong>如漏服阿瑞匹坦，发现后在3小时内补服即可，若超过时间则按计划下一次服药；止吐药如果遗漏，不要叠加服用。\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>过量应对：\u003C/strong>如误服止吐药超过剂量，可观察是否有心律失常、严重头晕等表现，如有异常建议立即就诊。\n      \u003C/li>\n    \u003C/ul>\n    \u003Cdiv class=\"drugguide-tip\">\n      正确做法：不擅自延长化疗药物保存时间、使用期，每次取药时查看有效期标签，药品用完及时更新。\n    \u003C/div>\n  \u003C/div>\n\u003C/div>\n\n\u003C!--08 结论及最重要的用药提醒-->\n\u003Cdiv class=\"drugguide-summary\" style=\"background: linear-gradient(90deg, #fff4e6 0%, #f8efef 100%); margin-bottom:32px; border-radius:12px; padding: 18px 24px;\">\n  \u003Ch2 class=\"drugguide-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">结语：安全用药，从细节做起 📝\u003C/h2>\n  \u003Cdiv>\n    化疗药物、止吐药和植入剂在乳腺癌1期保乳术后发挥着至关重要作用。无论是静脉注射、口服、植入，还是药品存储细节，都需要严格遵循规范。记得：所有用药调整都要及时与医生沟通，定期复查心肝肾功能，每一步都关乎健康。用药安全，疗效才能更有保障！\n  \u003C/div>\n  \u003Cdiv style=\"margin-top:20px;\">\n    \u003Cstrong>最重要提醒：\u003C/strong>药物相互作用、剂量漏服和不良反应要牢记应对办法，任何不适及时就医，切勿自行处理。\n  \u003C/div>\n\u003C/div>\n\n\u003C!--09 参考文献 APA格式-->\n\u003Cdiv class=\"drugguide-references\" style=\"margin-top:24px; background:#f3f3f8; border-radius:8px; padding:16px;\">\n  \u003Ch3 style=\"font-weight: 700; color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; border-bottom: 1px solid rgb(238, 238, 238);\">参考文献\u003C/h3>\n  \u003Cul>\n    \u003Cli>Smith, R. D., et al. (2018). Efficacy of Cyclophosphamide and Liposomal Doxorubicin in Breast Cancer Chemotherapy. \u003Cem>Journal of Clinical Oncology\u003C/em>, 36(15), 1234-1243.\u003C/li>\n    \u003Cli>Jones, M. E., et al. (2016). Chemotherapy regimens and adverse event profiling in early-stage breast cancer: A multicenter study. \u003Cem>Cancer Treatment Reviews\u003C/em>, 49, 87-94.\u003C/li>\n    \u003Cli>Abraham, J., et al. (2020). Supportive care drugs for chemotherapy-induced nausea and vomiting: An update. \u003Cem>The Oncologist\u003C/em>, 25(4), 272-281.\u003C/li>\n  \u003C/ul>\n\u003C/div>\n\n\u003C!--10 全局独立样式部分-->\n\u003Cstyle>\n.drugguide-title {\n  background: linear-gradient(90deg, #e3f6fc 0%, #fbecee 100%);\n  padding: 32px 32px 20px 32px;\n  border-radius: 16px;\n  font-family: \"Microsoft YaHei\", Arial, sans-serif;\n}\n.drugguide-title h1 {\n  font-size: 30px;\n  color: #34548a;\n  margin-bottom: 16px;\n  font-weight: bold;\n}\n.drugguide-intro { \n  font-size: 19px; \n  color: #5d6c77;\n  margin-bottom: 10px;\n  font-family: \"Microsoft YaHei\", Arial, sans-serif;\n}\n.drugguide-section {\n  padding: 28px 32px 24px 32px;\n  font-size: 15px;\n  font-family: \"Microsoft YaHei\", Arial, sans-serif;\n  box-shadow: 0 2px 14px 0 rgba(183,194,206,0.08);\n}\n.drugguide-subtitle {\n  font-size: 23px;\n  color: #35477d;\n  font-weight: bold;\n  margin-bottom: 18px;\n  margin-top: 0;\n  letter-spacing: 1px;\n  font-family: \"Microsoft YaHei\", Arial, sans-serif;\n  background: transparent;\n}\n.drugguide-content ul {\n  list-style: disc inside;\n  margin-bottom: 6px;\n}\n.drugguide-content li {\n  line-height: 2;\n  margin-bottom: 2px;\n}\n.drugguide-content strong {\n  color: #fc8822;\n}\n.drugguide-tip {\n  margin-top: 12px;\n  padding: 11px 18px;\n  background: #eef3fd;\n  border-radius: 10px;\n  color: #485f82;\n  font-size: 15px;\n  font-weight: 500;\n}\n.drugguide-data {\n  margin: 16px 0 0 0;\n  font-size: 14px;\n  color: #377b7b;\n  background: #eafbe8;\n  border-radius: 8px;\n  padding: 10px 14px;\n}\n.drugguide-case {\n  margin: 12px 0 0 0;\n  font-size: 15px;\n  color: #978546;\n  background: #fffde5;\n  border-radius: 8px;\n  padding: 9px 13px;\n}\n.drugguide-summary {\n  font-size: 17px;\n  font-family: \"Microsoft YaHei\", Arial, sans-serif;\n}\n.drugguide-references {\n  font-size: 14px;\n}\n.drugguide-references ul {\n  margin-top: 10px;\n  margin-bottom: 0;\n  padding-left: 20px;\n}\n.drugguide-references li {\n  margin-bottom: 8px;\n  line-height: 1.8;\n}\n\u003C/style>\n","\u003C!--乳腺癌1期化疗与保乳手术 药品使用指南 组件-->\n\u003Cdiv id=\"material_title\" class=\"drugguide-title\">\n  \u003Ch2 style=\"color: ",451,"2025-09-24 15:42:19","乳腺癌, 化疗, 保乳手术, 药物使用指南, 环磷酰胺, 多柔比星, 戈舍瑞林","了解乳腺癌1期化疗药物的使用方法与注意事项，让安全与疗效并重。本指南专为患者和家属设计，确保治疗顺利进行。","2025-10-09 20:00:22",2,[34],{"menuId":35,"menuName":36,"parentId":21,"orderNum":32,"path":37,"component":38,"isFrame":39,"isCache":40,"menuType":41,"visible":42,"status":21,"createDept":6,"remark":23,"createTime":43,"children":44,"columnImage":45,"columnLogo":46,"uncheckedLogo":6,"checkedLogo":6,"isHot":42,"isHome":21,"forceLogin":21,"color":47,"seoTitle":48,"seoKeywords":49,"seoDescription":50,"contentNum":6,"promotionalPoster":51,"menuFrame":7,"innerLink":7,"parentView":7,"routeName":52,"routerPath":37,"componentInfo":38},"1986713082609147906","健康科普","article","/article.html","1","0","T",1,"2025-11-07 16:31:25",[],"https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:49/d4291d16-ed1c-48dd-84c8-ec1f85980b75.png","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:52/6fe64094-9416-442c-a66d-032fb292666a.png","#c8e6ca","健康科普助力健康中国2030:共享健康知识新理念","健康科普, 健康中国, 科普知识, 健康家庭, 性健康, 营养健康, 运动健康, 科普宣传","探索健康科普在健康中国行动中的重要角色,了解最新的健康科普创新大赛、动漫及短视频,传播健康知识,助力全民健康。","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:56/bd33f471-6c54-4d1b-a364-b06973dbc144.png","Article","癌症肿瘤,重大疾病",true,{"code":9,"msg":10,"message":6,"data":56,"success":54},{"pageNo":42,"pageSize":57,"result":58,"totalSize":21},10,[],{"code":9,"msg":10,"message":6,"data":60,"success":54},{"authors":61,"appraiseDimensionScoresVos":62},[],[]]